Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study-Reference-Cited by-同舟云学术

Urinary microRNAs can predict response to abiraterone acetate in castration resistant prostate cancer: A pilot study

Published:2021-12-30 Issue:4 Volume:82 Page:475-482
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Snipaitiene Kristina¹²^ORCID,Bakavicius Arnas²³⁴^ORCID,Lazutka Juozas R.¹^ORCID,Ulys Albertas²^ORCID,Jankevicius Feliksas²⁴^ORCID,Jarmalaite Sonata¹²^ORCID

Affiliation:

1. Life Sciences Center, Institute of Biomedical Sciences Vilnius University Vilnius Lithuania

2. National Cancer Institute of Lithuania Vilnius Lithuania

3. Urology Centre Vilnius University Vilnius Lithuania

4. Faculty of Medicine Vilnius University Vilnius Lithuania

Funder

Lietuvos Mokslo Taryba

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24293

Reference30 articles.

1. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

2. Resistance to novel antiandrogen therapies in metastatic castration‐resistant prostate cancer;Boudadi K;Clin Med Insights Oncol,2016

3. Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review

4. Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

5. Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-05-21

2. Urinary microRNA profiling in pregnant women identifies placental microRNAs that are candidate biomarkers for monitoring placental health;FEBS Letters;2023-06-19

3. Current trends and challenges in point-of-care urinalysis of biomarkers in trace amounts;TrAC Trends in Analytical Chemistry;2022-12

4. A narrative review of the role of glucocorticoid receptors in prostate cancer: developments in last 5 years;Translational Andrology and Urology;2022-08

5. Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP;Journal of Cancer;2022